CMS said it will soon no longer provide Medicare Part D, or federal subsidies meant to keep premiums stable for prescription drug plans.

The Federal Trade Commission's case against telehealth company Hims & Hers was joined by officials in Utah and Los Angeles County, Fierce Healthcare reported. Other industry news is on a $47 million ...

Humana expects Medicare Advantage plan exits next year to affect around 600,000 members as the insurer continues to focus on margin recovery. “We will work to recapture a significant portion of that ...

Humana Inc. aims for a 3% pre-tax margin by 2028 via Medicare Advantage quality and cost cuts. Click for this HUM earnings ...

A subsidy program under Medicare Part D, which provides prescription drug coverage for millions of Americans through private ...

Humana stuck to its annual adjusted profit forecast on Wednesday for a second consecutive quarter, disappointing Wall Street ...

Humana maintained its 2026 adjusted profit outlook of at least $9 per share, which some analysts called a "disappointment" ...

The Part D Premium Stabilization Demonstration, which gave insurers billions to hold down drug premiums, will end after this ...

The health insurer revised its full-year GAAP earnings guidance to at least $6.52 a share, down from at least $8.36 ...

Washington is ending a subsidy that held down Medicare drug premiums. Officials say costs will barely move, but most of the ...

Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2026 (2Q26) versus the quarter ended June 30, 2025 (2Q25) and for ...

When a hospital system drops a Medicare Advantage contract, the patient's carefully chosen cardiologist can vanish overnight, ...